Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arcadia BiosciencesRKDA -18.59%43 3-1 Month Momentum % is -41.08% as of Aug. 13, 2026. GuruFocus rates RKDA with a GF Score™ of 43/100 and a GF Value™ of $2.84 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 2,045 Consumer Packaged Goods companies, Arcadia Biosciences ranks worse than 95.79% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-13), Arcadia Biosciences's 3-1 Month Momentum % is -41.08%.
The industry rank for Arcadia Biosciences's 3-1 Month Momentum % or its related term are showing as below:
RKDA's 3-1 Month Momentum % is ranked worse than 95.79% of 2045
companies
in the Consumer Packaged Goods industry
Industry Median: -3.69
vs RKDA: -41.08
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Arcadia Biosciences 3-1 Month Momentum % Related Terms
RKDA vs ORISF, ARRT, CIMG: 3-1 Month Momentum % Comparison
For the Packaged Foods subindustry, Arcadia Biosciences's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arcadia Biosciences 3-1 Month Momentum % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Arcadia Biosciences's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Arcadia Biosciences's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arcadia Biosciences (RKDA) has a 3-1 Month Momentum % of -41.08% as of Aug. 13, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Arcadia Biosciences and its competitors. According to the industry distribution chart, Arcadia Biosciences ranks #1959 out of 2045 companies in the Consumer Packaged Goods industry, placing it in the top 95.8%.
Is Arcadia Biosciences' 3-1 Month Momentum % too high?
Arcadia Biosciences' current 3-1 Month Momentum % is -41.08%. Based on the distribution chart, Arcadia Biosciences ranks #1959 out of 2045 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Arcadia Biosciences has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arcadia Biosciences' 3-1 Month Momentum % compare to ORISF and ARRT?
According to the Consumer Packaged Goods industry distribution chart, Arcadia Biosciences ranks #1959 out of 2045 companies for 3-1 Month Momentum %. This places Arcadia Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Consumer Packaged Goods company?
A good 3-1 Month Momentum % depends on the Consumer Packaged Goods industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Arcadia Biosciences and its competitors. Arcadia Biosciences's current 3-1 Month Momentum % is -41.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcadia Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Arcadia Biosciences (RKDA) is currently considered Possible Value Trap. The stock's GF Value™ is $2.84, compared to a current price of $0.56 — trading 80.3% below its estimated fair value. The current 3-1 Month Momentum % is -41.08%. Arcadia Biosciences' overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Arcadia Biosciences (RKDA), the current 3-1 Month Momentum % is -41.08% as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arcadia Biosciences (RKDA) Overvalued in 2026?
Based on GuruFocus' analysis, Arcadia Biosciences stock appears to be undervalued.
The current stock price of $0.56 is trading 80.3% below its estimated GF Value™ of $2.84.
GuruFocus considers Arcadia Biosciences to be Possible Value Trap.
Key valuation signals for RKDA:
3-1 Month Momentum %: -41.08%
GF Value™: $2.84 vs. price of $0.56 (80.3% below fair value)
No single metric tells the full story. See the RKDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
43GF Score
Get the complete analysis for RKDA
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RKDA has been successfully added to your 
